Sunday January 20, 2019

Practo joins hands with Uber to bring more relief to patients

0
//
Picture Courtesy:-www.bgr.in

Hyderabad: Practo, Asia’s largest healthcare booking platform, and Uber, the world’s leading ride-hailing technology platform, have announced today a global partnership that will make it easier and quicker for consumers to reach doctors.

Starting Monday, Practo users across India, Indonesia, Philippines and Singapore who book an appointment on Practo’s app will be able to see the closest Uber available when they get a reminder alert for their appointments, said a statement.

Users can then click the reminder notification and complete the booking process.

New users who book their first appointment on the Practo app can avail two free rides, up to Rs.200 per ride, with Uber. This offer is valid till December 31.

The partnership also comes with an inaugural offer specific to India, where any existing or new user booking an appointment on Practo till November 30 gets a free ride to and from the doctor’s clinic.

We realised that transportation issues often bring additional stress to a doctor’s visit — having to drive through traffic, then hunt for parking — all while you or your loved one is sitting in the car feeling ill is a terrible experience.

 

“There are also many patients who may not be able to drive themselves to a doctor at all. Our goal with this partnership is to completely remove this anxiety by integrating with Uber’s incredible experience and bringing that to our consumers,” said Practo founder and CEO N.D. Shashank.

Uber India president Amit Jain said: “The technology integration through this partnership reflects our common commitment to create seamless experience for all our user.”

(Inputs from IANS)

Next Story

New Sleeping Pill Can Help Patients Wake up in Response to Threat

However, more studies on humans are needed to confirm DORA safety and efficacy, they noted

0
Pills (representational Image), Pixabay

Japanese scientists have shown that a new class of sleeping pill that preserves the ability to wake in response to a threat, unlike the commonly prescribed drugs that muffles a sleeping brain’s “intruder alert”.

Even during sleep the brain continuously processes sensory information, waking us if it detects a threat. But the most widely prescribed class of sleeping pills, known as benzodiazepines, makes us less likely to rouse in response to sensory input.

The findings showed that millions prescribed on these sleeping pills would sleep through a fire alarm as someone vacuuming next to their bed.

 However, the new class of drugs called dual orexin receptor antagonists (DORAs) more selectively targeted the brain’s sleep or wake pathways, which gives them safety advantages over benzodiazepines, said researchers from the Kagoshima University.

These include a reduced “hangover effect”, with DORAs less likely to affect driving ability the day after use.

“Benzodiazepines stimulate the widespread brain receptor GABA-A, which makes us sleepy but also suppresses off-target brain areas – including the ‘gatekeeper’ that decides which sensory inputs to process,” explained author Tomoyuki Kuwaki, Professor at the varsity.

Contraception, Men
New sleeping pill can help patients wake up in response to threat.

In the study, published in Frontiers in Behavioral Neuroscience journal, mice that were given the new experimental hypnotic drug DORA-22 wake as quickly when threatened as drug-free sleepers — and then fall back asleep as quickly as ones given standard sleeping pills, once the threat is gone.

While DORA-22 allows mice to wake to a threat, it still helps them sleep.

Thus, the selectivity of DORAs could make them a safer alternative during sleep as well — by allowing the brain’s sensory gatekeeper to stay vigilant to threats, the researchers said.

Also Read- Here’s What Causes Cancer in Children

However, more studies on humans are needed to confirm DORA safety and efficacy, they noted.

“Although it remains to be seen whether DORAs have the same properties when used in humans, our study provides important and promising insight into the safety of these hypnotics,” Kuwaki said. (IANS)